Patent details

Basic Information

Publication number:

EP3520805

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP191614247

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOSITIONS FOR TREATING MYELOFIBROSIS

French Title of Invention:

PROCÉDÉS ET COMPOSITIONS POUR TRAITER DE LA MYÉLOFIBROSE

German Title of Invention:

ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON MYELOFIBROSE

SPC Number:

Dates

Filing date:

17/10/2012

Grant date:

10/03/2021

EP Publication Date:

07/08/2019

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/03/2021

EP B1 Publication Date:

10/03/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/10/2021

Expiration date:

17/10/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/03/2021

 

 

Name:

Acceleron Pharma Inc.

Address:

128 Sidney Street, Cambridge, MA 02139, United States (US)

Inventor

1

Name:

KUMAR, Ravindra

Address:

United States (US)

2

Name:

SEEHRA, Jasbir

Address:

United States (US)

3

Name:

PEARSALL, Robert, Scott

Address:

United States (US)

4

Name:

SURAGANI, Naga, Venkata Sai Rajasekhar

Address:

United States (US)

Priority

Priority Number:

201161547932 P

Priority Date:

17/10/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; A61K 38/17; A61K 38/45; A61K 45/06; A61P 7/06; C12N 9/12;

Publication

European Patent Bulletin

Issue number:

202110

Publication date:

10/03/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages